T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clinical Trial.

• Anna Sureda-Balari,
• M. José Terol,
• Eva Domingo-Domènech,
• Ana Pilar González Rodriguez,
• Francisca Hernández Mohedo,
• Javier Núñez Céspedes,
• Fátima De La Cruz Vicente,
• Carmen Martínez Muñoz,
• M. Elena Amutio Díaz,
• Raul Córdoba,
• Antonia Rodríguez Izquierdo,
• Samuel Romero Domínguez,
• Javier Briones Meijide,
• Richard Greil,
• Miriam Moreno Velázquez,
• Araceli Rubio,
• Mariana Bastos Oteiro,
• Pilar Gómez,
• Irit Avivi,
• María Casanova,
• Raquel Del Campo García,
• Victor Noriega,
• José Javier Sánchez Blanco,
• Ramón. García Sanz

Affiliations

Anna Sureda-Balari

1 Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain

M. José Terol

2 Hematology Department, Hospital Clínico Universitario, Valencia, Spain

Eva Domingo-Domènech

1 Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain

Ana Pilar González Rodriguez

3 Hematology Department, Hospital Central de Asturias, Oviedo, Asturias, Spain

Francisca Hernández Mohedo

4 Hematology Department, Hosputal Universitario Virgen de las Nievas, Granada, Spain

Javier Núñez Céspedes

5 Hematology Department. Hospital Universitario Marqués de Valdecilla, Santander, Spain

Fátima De La Cruz Vicente

6 Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain

Carmen Martínez Muñoz

7 Hematology Department, Hospital Clínic, Barcelona, Spain

M. Elena Amutio Díaz

8 Hematology Department, Hospital de Cruces, Bilbao, Spain

Raul Córdoba

9 Hematology Department, Fundación Jiménez Díaz, Madrid, Spain

Antonia Rodríguez Izquierdo

10 Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

Samuel Romero Domínguez

11 Hematology Department, Hospital Universitario La Fe, Valencia, Spain

Javier Briones Meijide

12 Hematology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain

Richard Greil

13 alzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Salzburg

Miriam Moreno Velázquez

16 Hematology Department, Institut Català d’Oncologia-Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain

Araceli Rubio

17 Hematology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain

Mariana Bastos Oteiro

18 Hematology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain

Pilar Gómez

19 Hematology Department, Hospital Universitario La Paz, Madrid, Spain

Irit Avivi

20 Hematology Department, Tel Aviv Sourasky Medical Center, Israel

María Casanova

21 Hematology Department, Hospital Costa del Sol, Málaga, Spain

Raquel Del Campo García

22 Hematology Department, Hospital Son Llatzer, Palma de Mallorca, Spain

Victor Noriega

23 Complejo Hospital Universitario A Coruña, Spain

José Javier Sánchez Blanco

24 Hematology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain

Ramón. García Sanz

25 Hematology Department, Hospital Clínico Universitario de Salamanca, Salamanca, Spain